title: Mannitol treatment in central nervous system lupus.
authors.forename: M
authors.initials: M
authors.lastname: Eren
authors.forename: E
authors.initials: E
authors.lastname: Baskin
authors.forename: A
authors.initials: A
authors.lastname: Cila
authors.forename: S
authors.initials: S
authors.lastname: Ozen
mesh_terms: D000284:Administration, Oral; D000493:Allopurinol / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D016166:Free Radical Scavengers / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008181:Lupus Nephritis / Q000150:complications / Q000188:drug therapy; D020945:Lupus Vasculitis, Central Nervous System / Q000150:complications / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008353:Mannitol / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D016166:Free Radical Scavengers; D008353:Mannitol; D000493:Allopurinol; D003520:Cyclophosphamide; D011239:Prednisolone; D008775:Methylprednisolone